Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Arcus Biosciences (RCUS) Leases: 2020-2022

Historic Leases for Arcus Biosciences (RCUS) over the last 2 years, with Sep 2022 value amounting to $102.1 million.

  • Arcus Biosciences' Leases rose 186.72% to $102.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $102.1 million, marking a year-over-year increase of 186.72%. This contributed to the annual value of $105.0 million for FY2021, which is 721.28% up from last year.
  • As of Q3 2022, Arcus Biosciences' Leases stood at $102.1 million, which was down 1.88% from $104.0 million recorded in Q2 2022.
  • In the past 5 years, Arcus Biosciences' Leases ranged from a high of $105.0 million in Q4 2021 and a low of $12.2 million during Q1 2021.
  • For the 3-year period, Arcus Biosciences' Leases averaged around $63.9 million, with its median value being $69.1 million (2021).
  • Data for Arcus Biosciences' Leases shows a peak YoY spiked of 741.23% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Arcus Biosciences' Leases stood at $12.8 million in 2020, then surged by 721.28% to $105.0 million in 2021, then skyrocketed by 186.72% to $102.1 million in 2022.
  • Its last three reported values are $102.1 million in Q3 2022, $104.0 million for Q2 2022, and $103.0 million during Q1 2022.